MyPharmacy+

Vomiflux Syrup

Manufactured By Pfimaxx Organics Pvt Ltd

Salt Synonyms

Rs. 30.40

MRP 32.00

(5% OFF)

Includes all taxes

Package SIZE

bottle of 30 ml Syrup

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Vomiflux Syrup

Uses / Indications:

Use as directed on the label or as directed by your physician

Introduction:

Vomiflux Syrup is formulated with ondansetron that helps to control nausea and vomiting.

How to use:

This medicine is formulated with ondansetron that helps to control nausea and vomiting|It may also prevent nausea and vomiting caused due to any surgery cancer drug therapy or radiotherapy|This medication is a 5-HT3 receptor antagonist

Description:

Helps to control nausea and vomiting|May prevent nausea and vomiting caused due to any surgery cancer drug therapy or radiotherapy|Dietary syrup

Benefits:

Safety Advise:

Read the product label carefully before use|Store in a cool and dry place away from direct sunlight|Keep out of reach of children|Consult a doctor before taking any supplement|Do not exceed the recommended dosage|Pregnant or nursing mothers children and people with medical conditions must consult a physician before taking this supplement|</div

Vomiflux Syrup

Manufactured By Pfimaxx Organics Pvt Ltd

Salt Synonyms

Rs. 30.40

MRP 32.00

Includes all taxes

Package SIZE

Available Substitutes

1-CC Oral Suspension Sugar Free

Azure Pharmaceuticals

1 Tree Co Q 10 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Omega 3 6 9 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Sleep Tight Oral Spray Strawberry

Saisir Global Technologies Pvt Ltd

10 AM Vegetable Capsule

Kachhela Medex Pvt Ltd

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: